Skip to main content

Application of Contrast-Enhanced Ultrasound in the Evaluation of Clinical Effect of Microwave Ablation of Hepatocellular Carcinoma: Comparison with Other Imaging Modalities

  • Chapter
  • First Online:
Microwave Ablation Treatment of Solid Tumors
  • 1182 Accesses

Abstract

Image-guided percutaneous ablation therapy for hepatocellular carcinoma has been used worldwide, and the most widely used modalities are radiofrequency ablation (RF) and microwave ablation (MA). Multiphasic contrast-enhanced CT, dynamic MRI, and contrast-enhanced ultrasound are accepted as reliable modalities for evaluating the adequacy of radiofrequency and microwave ablation and early detection of tumor recurrences. In this session, we evaluate the clinical utility of low mechanical index contrast-enhanced ultrasound in assessing percutaneous microwave ablation response in patients with hepatocellular carcinoma by comparing the results to contrast-enhanced magnetic resonance imaging and prove that contrast-enhanced ultrasound examination is a safe and easy modality in assessing therapeutic effect of microwave ablation.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Tang Z-Y. Hepatocellular carcinoma-cause, treatment and metastasis. World J Gastroenterol. 2006;7:445–54.

    Google Scholar 

  2. Lai EC, Fan ST, Lo CM, Chu KM, Liu CL, Wong J. Hepatic resection for hepatocellular carcinoma: an audit of 343 patients. Ann Surg. 1995;221:291–8.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  3. Lau WY, Leung TW, Yu SC, Ho SK. Percutaneous local ablative therapy for hepatocellular carcinoma: a review and look into the future. Ann Surg. 2003;237:171–9.

    PubMed Central  PubMed  CAS  Google Scholar 

  4. Liang P, Dong B, Yu X, Yu D, Wang Y, Feng L, Xiao Q. Prognostic factors for survival in patients with hepatocellular carcinoma after percutaneous microwave ablation. Radiology. 2005;235:299–307.

    Article  PubMed  Google Scholar 

  5. Solbiati L, Ierace T, Tonolini M, Osti V, Cova L. Radiofrequency thermal ablation of hepatic metastases. Eur J Ultrasound. 2001;13:149–58.

    Article  PubMed  CAS  Google Scholar 

  6. Antoch G, Kuehl H, Vogt FM, Debatin JF, Stattaus J. Value of CT volume imaging for optimal placement of radiofrequency ablation probes in liver lesions. J Vasc Interv Radiol. 2002;13:1155–61.

    Article  PubMed  Google Scholar 

  7. Kono Y, Lucidarme O, Choi SH. Contrast-enhanced ultrasound as a predictor of treatment efficacy within 2 weeks after transarterial chemoembolization of hepatocellular carcinoma. J Vasc Interv Radiol. 2007;18(1 Pt 1):57–65.

    Article  PubMed  Google Scholar 

  8. Schneider M, Arditi M, Barrau MB, Brochot J, Broillet A, Ventrone R, Yan F. BR1: a new ultrasonographic contrast agent based on sulfur hexafluoride-filled microbubbles. Invest Radiol. 1995;30(8):451–7.

    Article  PubMed  CAS  Google Scholar 

  9. Liang P, Dong B, Yu X, Yang Y, Yu D, Su L, Xiao Q, Sheng L. Prognostic factors for percutaneous microwave coagulation therapy of hepatic metastases. AJR Am J Roentgenol. 2003;181:1319–25.

    Article  PubMed  Google Scholar 

  10. Dong B, Liang P, Yu X, Su L, Yu D, Cheng Z, Zhang J. Percutaneous sonographically guided microwave coagulation therapy for hepatocellular carcinoma: results in 234 patients. AJR Am J Roentgenol. 2003;180:1547–55.

    Article  PubMed  Google Scholar 

  11. Zhou P, Liang P, Yu X, Wang Y, Dong B. Percutaneous microwave ablation of liver cancer adjacent to the gastrointestinal tract. J Gastrointest Surg. 2009;13:318–24.

    Article  PubMed  Google Scholar 

  12. Liang P, Wang Y, Yu X, Dong B. Malignant liver tumors: treatment with percutaneous microwave ablation-complications among cohort of 1136 patients. Radiology. 2009;251(3):933–40. Epub 2009 Mar 20.

    Article  PubMed  Google Scholar 

  13. Kondo H, Kanematsu M, Hoshi H, et al. Preoperative detection of malignant hepatic tumors: comparison of combined methods of MR imaging with combined methods of CT. AJR. 2000;174:947–54.

    Article  PubMed  CAS  Google Scholar 

  14. Takahiro D, Ei K, Ikuhiro Y, Kouichi M, Shigetoshi O, Tomomi S, Daisuke S, Wataru S, Yumiko A, Hajime I, Kentaro K, Takashi G, Hirohide O. Efficacy of contrast-enhanced ultrasonography in radiofrequency ablation for hepatocellular carcinoma. Intern Med. 2012;51(1):1–7. Epub 2012 Jan 1.

    Article  Google Scholar 

  15. Goldberg SN, Gazelle GS, Mueller PR. Thermal ablation therapy for focal malignancy: a unified approach to underlying principles, techniques, and diagnostic imaging guidance. AJR. 2000;174:323–31.

    Article  PubMed  CAS  Google Scholar 

  16. Lencioni R, Cioni D, Goletti O, et al. Radiofrequency thermal ablation of liver tumors: state-of-the-art. Cancer J. 2000;6 suppl 4:S304–15.

    Google Scholar 

  17. Lencioni R, Cioni D, Bartolozzi C. Percutaneous radiofrequency thermal ablation of liver malignancies: techniques, indications, imaging findings, and clinical results. Abdom Imaging. 2001;26:345–36.

    Article  PubMed  CAS  Google Scholar 

  18. Sironi S, Livraghi T, Meloni F, De Cobelli F, Ferrero C, Del Maschio A. Small hepatocellular carcinoma treated with percutaneous RF ablation: MR imaging follow-up. AJR. 1999;173:1225–9.

    Article  PubMed  CAS  Google Scholar 

  19. Dromain C, de Baere T, Elias D, Kuoch V, Ducreux M, Boige V, Petrow P, Roche A, Sigal R. Hepatic tumor treated with percutaneous radio-frequency ablation: CT and MR imaging follow-up. Radiology. 2002;223:255–62.

    Article  PubMed  Google Scholar 

  20. Chopra S, Dodd III GD, Chintapalli KN, Leyendecker JR, Karahan OI, Rhim H. Tumor recurrence after radiofrequency thermal ablation of hepatic tumors: spectrum of findings on dual-phase contrast-enhanced CT. AJR Am J Roentgenol. 2001;177:381–7.

    Article  PubMed  CAS  Google Scholar 

  21. Vogl TJ, Schwarz W, Blume S, et al. Preoperative evaluation of malignant liver tumors: comparison of unenhanced and SPIO (Resovist)-enhanced MR imaging with biphasic CTAP and intraoperative US. Eur Radiol. 2003;13:262–72.

    PubMed  Google Scholar 

  22. Semelka RC, Cance WG, Marcos HB, Mauro MA. Liver metastases: comparison of current MR techniques and spiral CT during arterial portography for detection in 20 surgically staged cases. Radiology. 1999;213:86–91.

    Article  PubMed  CAS  Google Scholar 

  23. Solbiati L, Ierace T, Goldberg SN, Sironi S, Livraghi T, Fiocca R, Servadio G, Rizzatto G, Mueller PR, Del Maschio A, Gazelle GS. Percutaneous US-guided radio-frequency tissue ablation of liver metastases: treatment and follow-up in 16 patients. Radiology. 1997;202:195.

    Article  PubMed  CAS  Google Scholar 

  24. Livraghi T, Goldberg SN, Monti F, Bizzini A, Lazzaroni S, Meloni F, Pellicanò S, Solbiati L, Gazelle GS. Saline-enhanced radio-frequency tissue ablation in the treatment of liver metastases. Radiology. 1997;202:582.

    Article  Google Scholar 

  25. Tsuda M, Majima K, Yamada T, et al. Hepatocellular carcinoma after radiofrequency ablation therapy: dynamic CT evaluation of treatment. Clin Imaging. 2001;25:409–15.

    Article  PubMed  CAS  Google Scholar 

  26. Darby S, Berrington de Gonza’lez A. Risk of from diagnostic X-rays; estimates for the UK and 14 other countries. Lancet. 2004;363.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Qu, P. et al. (2015). Application of Contrast-Enhanced Ultrasound in the Evaluation of Clinical Effect of Microwave Ablation of Hepatocellular Carcinoma: Comparison with Other Imaging Modalities. In: Liang, P., Yu, Xl., Yu, J. (eds) Microwave Ablation Treatment of Solid Tumors. Springer, Dordrecht. https://doi.org/10.1007/978-94-017-9315-5_30

Download citation

  • DOI: https://doi.org/10.1007/978-94-017-9315-5_30

  • Published:

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-017-9314-8

  • Online ISBN: 978-94-017-9315-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics